PTP4A3 and melanoma: Consistent with MHCC liver tumors, we observed a similar increase in PRL3 surface+ cells in metastatic lung tumors formed by tail vein injection of B16F0 melanoma cells (Supplementary Fig. 2a), which express endogenous PRL3 and respond well to PRL3 antibody therapy8.